Nectar Lifesciences Limited

NSEI:NECLIFE Stock Report

Market Cap: ₹9.4b

Nectar Lifesciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Amit Chadah

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.2yrs
CEO ownershipn/a
Management average tenure2.1yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Nectar Lifesciences (NSE:NECLIFE) Seems To Use Debt Quite Sensibly

Dec 15
Nectar Lifesciences (NSE:NECLIFE) Seems To Use Debt Quite Sensibly

Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive

Oct 11
Revenues Working Against Nectar Lifesciences Limited's (NSE:NECLIFE) Share Price Following 26% Dive

Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth

Aug 22
Nectar Lifesciences Limited (NSE:NECLIFE) Shares Fly 31% But Investors Aren't Buying For Growth

Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden

Jul 27
Here's Why Nectar Lifesciences (NSE:NECLIFE) Has A Meaningful Debt Burden

Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Feb 19
Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Dec 22
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Jun 16
Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jun 21
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Jul 29
Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt

Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Feb 25
Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?

Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Jan 21
Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet

Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Nov 02
Zooming in on NSE:NECLIFE's 0.3% Dividend Yield

Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

Sep 07
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?

If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

Aug 09
If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today

The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

Aug 09
The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More

What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

Jul 13
What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E

CEO

Amit Chadah (54 yo)

4.2yrs

Tenure

Mr. Amit Chadah serves as the Chief Executive Officer of Nectar Lifesciences Limited since October 30, 2020. He was President of Business Development until October 30, 2020. He has joined the Nectar Lifesc...

Leadership Team

NamePositionTenureCompensationOwnership
Sanjiv Goyal
Chairman & MDno data₹22.65m44.35%
₹ 4.2b
Puneet Sud
Director of Operations & Wholetime Directorno data₹6.46mno data
Amit Chadah
Chief Executive Officer4.2yrsno datano data
Sushil Kapoor
Chief Financial Officer2.1yrsno datano data
Vikas Vij
Chief Operating Officerless than a yearno datano data
Neha Vaishnav
Company Secretary & Compliance Officer2yrsno datano data

2.1yrs

Average Tenure

57yo

Average Age

Experienced Management: NECLIFE's management team is considered experienced (2.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sanjiv Goyal
Chairman & MDno data₹22.65m44.35%
₹ 4.2b
Puneet Sud
Director of Operations & Wholetime Director2.3yrs₹6.46mno data
Meena Verma
Nominee Director5.8yrs₹80.00kno data
Rupinder Tewari
Independent & Non-Executive Director5.8yrs₹75.00kno data
Kuldip Bhasin
Independent & Non-Executive Director3.3yrs₹120.00kno data
Indu Kaur
Independent & Non-Executive Director2.3yrs₹120.00kno data

3.3yrs

Average Tenure

61.5yo

Average Age

Experienced Board: NECLIFE's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:53
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nectar Lifesciences Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Naveed MD.FirstCall Research